CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-27 | Ross Leonard S | Exercise or conversion · Restricted Stock Units | −6,667 | 6,667 | ||
| 2019-06-27 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion | +10,000 | 48,437 | ||
| 2019-06-27 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,940 | $1.65 | $5K | 45,497 |
| 2019-06-27 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −10,000 | 10,000 | ||
| 2019-06-27 | Lurker Nancy President & CEO | Exercise or conversion | +40,000 | 325,200 | ||
| 2019-06-27 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −40,000 | 40,000 | ||
| 2019-06-25 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | Mazzo David J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | Duker Jay S. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | Godshall Douglas Evan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | Peterson Kristine Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-06-25 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-06-25 | Lurker Nancy President & CEO | Grant or award · Restricted Stock Units | +411,523 | 411,523 | ||
| 2019-06-25 | Lurker Nancy President & CEO | Grant or award · Stock Option (Right to Buy) | +930,000 | 930,000 | ||
| 2019-06-25 | Price David CFO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-06-25 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +370,000 | 370,000 | ||
| 2019-06-21 | ROGERS MICHAEL W Director | Exercise or conversion | +6,667 | 119,167 | ||
| 2019-06-21 | ROGERS MICHAEL W Director | Exercise or conversion · Deferred Stock Units | −6,667 | 0 | ||
| 2019-06-21 | Mazzo David J Director | Exercise or conversion | +8,333 | 166,333 |
Page 35 of 40 · 795 trades